1500005I dynport vaccine company, LLC; phase 1 clinical trials units for therapeutics against infectious diseases; to 16-0110.B1.0066--05 base task order funding; carb can 8023349
Ended Awarded Last action
- Contract number
- HHSN27200006
- Awardee
-
Dynport Vaccine Company LLC UEI LXNEGTYDR755
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,860,187
Award facts
- Opportunity
-
- NIAIDDMIDNIHAI2013178 Solicitation number
- Contract value 100% obligated
- $3,860,186.71 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Durham, NC 27705, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$5,903 | |
| Funding Only Action | -$236,969 | |
| Supplemental Agreement for work within scope | $19,597 | |
| Original award | $4,083,461 |
About this award
The National Institute of Allergy and Infectious Diseases issued a delivery order to Dynport Vaccine Company LLC on June 13, 2017, with a ceiling value of $3.86 million under the Therapeutics Against Infectious Diseases Phase 1 parent IDIQ for Phase 1 clinical trial services.
The order funds Phase 1 clinical trial unit operations and study task area B activities supporting therapeutics development against infectious diseases. Place of performance is Durham, North Carolina. The award carries a cost-plus-fixed-fee pricing structure with an ultimate completion date of November 7, 2020. No set-aside was applied to this delivery order.
Quick answers
Who was awarded contract HHSN27200006?
HHSN27200006 was awarded to Dynport Vaccine Company LLC by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on June 13, 2017.
How much is contract HHSN27200006 worth?
The government has obligated $3,860,187 on HHSN27200006.
Is contract HHSN27200006 an order under another contract?
Yes. HHSN27200006 is a delivery order under HHSN272201500005I, an indefinite delivery contract, on Therapeutics Against Infectious Diseases Phase 1.
Was contract HHSN27200006 competed?
The extent of competition for HHSN27200006 was full and open competition. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award